---
title: Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.
date: '2023-11-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37937763
source: Trending page - PubMed
description: <span class="authors-list-item "><a class="full-name" href="https://pubmed.ncbi.nlm.nih.gov/?term=Planchard+D&amp;cauthor_id=37937763"
  ref="linksrc=author_name_link" data-ga-category="search" data-ga-action="author_link"
  data-ga-label="David Planchard">David Planchard</a><sup class="affiliation-links"><span
  class="author-sup-separator">&nbsp;</span><a class="affiliation-link" title="From
  the Department of Medical Oncology, Institut Gustave Roussy, Thoracic Group and
  International Center for Thoracic Cancers, Villejuif, and the Faculty of Medicine,
  Paris-Saclay University, Paris - both in ...
disable_comments: true
---
<span class="authors-list-item "><a class="full-name" href="https://pubmed.ncbi.nlm.nih.gov/?term=Planchard+D&amp;cauthor_id=37937763" ref="linksrc=author_name_link" data-ga-category="search" data-ga-action="author_link" data-ga-label="David Planchard">David Planchard</a><sup class="affiliation-links"><span class="author-sup-separator">&nbsp;</span><a class="affiliation-link" title="From the Department of Medical Oncology, Institut Gustave Roussy, Thoracic Group and International Center for Thoracic Cancers, Villejuif, and the Faculty of Medicine, Paris-Saclay University, Paris - both in ...